Cotinga Pharmaceuticals Inc. (COTQF)

[rbd317]

$COTQF - IND filing with the FDA in April 2015 (publishing on-going) and Phase 1 Clinical Trial after...

Research programme: cancer therapeutics - Critical Outcome Technologies

10/30/2014 - Critical Outcome Technologies completes two-species IND-enabling toxicity studies towards IND filing with the US FDA in Cancer ()

10/21/2014 - Critical Outcome Technologies and The University of Texas MD Anderson Cancer Center sign a material transfer agreement for the development of COTI 2 for Head and neck cancer ()

9/10/2014 - Preclinical pharmacodynamics data in Cancer released by Critical Outcome Technologies ()

9/8/2014 - Critical Outcome Technologies and University of Texas MD Anderson Cancer Center sign letter of intent for phase I development of COTI 2 ()

6/17/2014 - Research programme: cancer therapeutics - Critical Outcome Technologies receives Orphan Drug status for Ovarian cancer in USA

6/4/2014 - Research programme: cancer therapeutics - Critical Outcome Technologies is available for licensing as of 4 June 2014. http://www.criticaloutcome.com

4/4/2014 - Critical Outcome Technologies submits orphan drug application for COTI-2 for Ovarian cancer in USA ()

11/30/2013 - Early research in Colorectal cancer in Canada (unspecified route)

6/11/2013 - Preclinical pharmacodynamics data in Cancer released by Critical Outcome Technologies ()

11/30/2013 - Early research in Colorectal cancer in Canada (unspecified route)

6/11/2013 - Preclinical pharmacodynamics data in Cancer released by Critical Outcome Technologies ()

12/13/2012 - Pharmacodynamics data from a preclinical trial in Cancer released by Critical Outcome Technologies ()

9/20/2012 - Pharmacodynamics data from preclinical studies in Cancer released by Critical Outcome Technologies ()

8/16/2011 - Pharmacodynamics data from several preclinical studies in cancer released by Critical Outcome Technologies ()

6/28/2011 - Pharmacodynamics and adverse events data from animal studies in cancer released by Critical Outcome
Technologies ()

2/2/2011 - Preclinical development is ongoing in USA and Canada

6/10/2010 - Preclinical development is ongoing in USA and Canada

3/30/2010 - Preclinical pharmacodynamics data released by Critical Outcome Technologies ()

1/12/2010 - Critical Outcome Technologies and Translational Genomics Research Institute enter into agreement to complete research for an IND filing for COTI 2 ()

12/11/2009 - Preclinical safety data in Cancer released by Critical Outcome Technologies ()

10/28/2009 - Pharmacodynamics data from a preclinical trial in Cancer released by Critical Outcome Technologies ()

10/15/2009 - Pharmacodynamics and adverse events data from a preclinical trial in Cancer released by Critical Outcome
Technologies ()

8/18/2009 - Pharmacodynamics data from a preclinical trial in Cancer released by Critical Outcome Technologies ()

8/6/2009 - Pharmacodynamics data from in vitro studies in cancer released by Critical Outcome Technologies ()

7/2/2009 - Efficacy and adverse events data from an animal study in ovarian cancer released by Critical Outcome Technologies
()

5/14/2009 - Preclinical pharmacodynamics data released by Critical Outcome Technologies ()

2/9/2009 - Pharmacodynamics data from a preclinical trial in Cancer released by Critical Outcome Technologies Inc. ()

12/18/2008 - This programme is still in active development

8/21/2007 - Preclinical trials in Small cell lung cancer in Canada (PO)